Radioligand–Antibody Conjugates: Integrating Antibody Engineering, Chelator Chemistry, and Radioligands for Precision Theranosis
- 19 December 2025
- journal article
- review article
- Published by Springer Nature in Molecular Diagnosis & Therapy
- Vol. 30 (2) , 259-280
Abstract
Radioligand–antibody conjugates (RadioBodies), also known as radiolabeled antibodies, represent an emerging class that enables targeted delivery of rKeywords
Funding Information
- Department of Biotechnology (BT/PR42965/PBD/26/821/2021)
- Department of Biotechnology (Grant No. BT/PR62235/2025)
- Centre of excellence of Antibacterial and antiviral (NPLC-CoE-AHP)
- National Institute of Pharmaceutical Education and Research, S.A.S. Nagar (NPLC-AHP)
This publication has 170 references indexed in Scilit:
- CD38-specific immunoPET imaging for multiple myeloma diagnosis and therapeutic monitoring: preclinical and first-in-human studiesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2024
- Engineered Antibodies as Cancer RadiotheranosticsAdvanced Science, 2024
- [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- Synthesis and preclinical investigation of 99mTc-p-SCN-Bzl-DTPA-cetuximab for targeting EGFR using head and neck squamous cell carcinoma (HNSCC) xenograftsMolecular Biology Reports, 2019
- Aligning physics and physiology: Engineering antibodies for radionuclide deliveryJournal of Labelled Compounds and Radiopharmaceuticals, 2018
- Development of Lu‐177‐trastuzumab for radioimmunotherapy of HER2 expressing breast cancer and its feasibility assessment in breast cancer patientsInternational Journal of Cancer, 2016
- Repeated adjuvant anti‐CEA radioimmunotherapy after resection of colorectal liver metastases: Safety, feasibility, and long‐term efficacy results of a prospective phase 2 studyCancer, 2016
- Targeting human prostate cancer with 111In‐labeled D2B IgG, F(ab′)2 and Fab fragments in nude mice with PSMA‐expressing xenograftsContrast Media & Molecular Imaging, 2014
- Auger radiation targeted into DNA: a therapy perspectiveEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- Mechanism of Cytotoxicity Induced by Chimeric Mouse Human Monoclonal Antibody IDEC-C2B8 in CD20-Expressing Lymphoma Cell LinesCellular Immunology, 2000